Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 37, Issue 2, Pages 340-348
Publisher
Wiley
Online
2021-11-17
DOI
10.1002/jbmr.4472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
- (2021) Hiroaki Ikesue et al. SUPPORTIVE CARE IN CANCER
- Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
- (2021) Hiroaki Ikesue et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis
- (2021) Kazumitsu Aoki et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
- (2021) Peter Burckhardt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator‐mandated cohort postauthorization safety study in Denmark, Norway, and Sweden
- (2021) Vera Ehrenstein et al. CANCER
- Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
- (2021) Lianghai Jiang et al. Journal of Orthopaedic Surgery and Research
- Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed
- (2020) Serge Ferrari et al. BONE
- Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals
- (2020) Reddy Neha et al. International Journal of Clinical Pharmacy
- Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study
- (2020) Se Hwa Kim et al. BONE
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medication‐related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications
- (2020) Leanne Teoh et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis
- (2020) Akanksha Srivastava et al. SUPPORTIVE CARE IN CANCER
- Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study
- (2020) J. Everts-Graber et al. BONE
- Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated With Denosumab for up to 10 Years
- (2019) Nelson B Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases
- (2019) Anna Yuan et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- A comparison of the cone beam computed tomography (CBCT) findings in medication-related osteonecrosis of the jaws (MRONJ) related to denosumab vs. bisphosphonates: an observational pilot study
- (2019) Sarina E.C. Pichardo et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis
- (2018) P. J. Voss et al. Odontology
- Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab
- (2018) Noam Yarom et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw
- (2018) Sun-Young Jung et al. ORAL DISEASES
- Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw
- (2018) J. Chang et al. Current Osteoporosis Reports
- Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study
- (2018) T. Hasegawa et al. OSTEOPOROSIS INTERNATIONAL
- What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review
- (2017) Suad Aljohani et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
- (2017) P. A. Eiken et al. OSTEOPOROSIS INTERNATIONAL
- Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
- (2017) Tine Loyson et al. ACTA CLINICA BELGICA
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
- (2014) Salvatore L. Ruggiero et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
- (2014) John T. Grbic et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population
- (2014) T.-C. Lin et al. OSTEOPOROSIS INTERNATIONAL
- Osteonecrosis of the Jaw in Sweden Associated With the Oral Use of Bisphosphonate
- (2013) Mattias Ulmner et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Conservative management of bisphosphonate-related osteonecrosis of the jaws: Staging and treatment outcomes
- (2013) Mark A. Lerman et al. ORAL ONCOLOGY
- Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis
- (2012) Patricia Tennis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons
- (2011) A. A. KHAN et al. JOURNAL OF RHEUMATOLOGY
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update
- (2009) Salvatore L. Ruggiero et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now